Home/Filings/4/0001104659-23-110116
4//SEC Filing

Groman Dan 4

Accession 0001104659-23-110116

CIK 0001868912other

Filed

Oct 18, 8:00 PM ET

Accepted

Oct 19, 4:15 PM ET

Size

5.1 KB

Accession

0001104659-23-110116

Insider Transaction Report

Form 4
Period: 2023-10-17
Groman Dan
Chief Technology Officer
Transactions
  • Sale

    Class A Common Stock

    2023-10-17$9.09/sh5,000$45,450138,828 total
Footnotes (2)
  • [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 15, 2023.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.00 to $9.16. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.

Issuer

Enfusion, Inc.

CIK 0001868912

Entity typeother

Related Parties

1
  • filerCIK 0001881296

Filing Metadata

Form type
4
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 4:15 PM ET
Size
5.1 KB